An Egyptian study combining SMN2 and NAIP genotypes found that NAIP deletion plus low SMN2 was associated with the worst outcomes, while NAIP intact plus higher SMN2 was associated with milder SMA [4]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.